CVS Health Corp. said it is working “productively” with U.S. regulators to get its $68 billion acquisition of health insurer Aetna Inc. approved, and the process is moving along as expected.
The deal may be approved in the third quarter or early in the fourth quarter, CVS said in its earnings statement on Wednesday. That’s a narrower timeframe than the company had previously provided.
CVS has dodged one hurdle in its bid to buy insurer Aetna Inc., as antitrust enforcers don’t see competitive problems that can stem from uniting companies that operate at different levels of a supply chain, Bloomberg ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.